MK-8353 shows promise for melanoma with BRAF or RAS mutations
An investigational compound designed to block a hyperactive cell growth…
An investigational compound designed to block a hyperactive cell growth signal in advanced melanoma and other cancers has shown some promise in an early-stage clinical trial...